|1.||McLaurin, JoAnne: 5 articles (10/2012 - 06/2007)|
|2.||Yoshida, Ken-ichi: 3 articles (09/2014 - 01/2011)|
|3.||Nitz, Mark: 3 articles (10/2011 - 08/2008)|
|4.||Tanaka, Kosei: 2 articles (09/2014 - 01/2013)|
|5.||Choi, Ji-Kyung: 2 articles (12/2013 - 09/2010)|
|6.||Dedeoglu, Alpaslan: 2 articles (12/2013 - 09/2010)|
|7.||Jenkins, Bruce G: 2 articles (12/2013 - 09/2010)|
|8.||Carreras, Isabel: 2 articles (12/2013 - 09/2010)|
|9.||Takenaka, Shinji: 2 articles (01/2013 - 01/2011)|
|10.||Caldarelli, Stefano: 2 articles (12/2012 - 06/2012)|
|1.||Alzheimer Disease (Alzheimer's Disease)
06/01/2007 - "Our laboratory has shown that scyllo-inositol inhibits cognitive deficits in TgCRND8 mice and significantly ameliorates disease pathology, suggesting it might be effective in treating Alzheimer's disease (AD). "
01/01/2013 - "An improved Bacillus subtilis cell factory for producing scyllo-inositol, a promising therapeutic agent for Alzheimer's disease."
01/01/2012 - "Preclinical development of scyllo-inositol for the treatment of Alzheimer's disease (AD) has been investigated in both in vitro and in vivo models with positive results. "
09/27/2011 - "A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease."
01/01/2012 - "scyllo-Inositol, preclinical, and clinical data for Alzheimer's disease."
|2.||Breast Neoplasms (Breast Cancer)
10/07/2009 - "A novel PET radiotracer, [18F]-1-deoxy-1-fluoro-scyllo-inositol, was synthesized via a one-pot reaction in 16 +/- 3% uncorrected radiochemical yield within 80 minutes; although this compound revealed low brain penetration it shows promise in rodent tumour models for breast cancer imaging."
10/01/2011 - "The aim of the study was to evaluate the uptake of [(18)F]-1-deoxy-1-fluoro-scyllo-inositol ([(18)F]-scyllo-inositol) in human breast cancer (BC) and glioma xenografts, as well as in inflammatory tissue, in immunocompromised mice. "
|3.||Prostatic Neoplasms (Prostate Cancer)
11/01/2003 - "In addition, taurine, myo-inositol, and scyllo-inositol were all higher in prostate cancer vs. healthy glandular and stromal tissues. "
05/01/2008 - "Furthermore, a study carried out on 10 healthy subjects shows that the six prostate metabolites creatine (Cr), total choline (Cho), Cit, Spm, mI, and scyllo-inositol (sI) can be reliably detected in vivo, some of which--especially total Cho and Cit--have proven to be useful markers for the detection of prostate cancer."
10/01/2011 - "Uptake of [(18)F]-scyllo-inositol in inflammation was lower than [(18)F]-FDG. "
10/01/2011 - "Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice."
10/01/2011 - "Tumour, inflammation and normal tissue uptakes were evaluated by biodistribution studies and positron emission tomography (PET) imaging using [(18)F]-scyllo-inositol and [(18)F]-FDG in mice bearing subcutaneous MDA-MB-231, MCF-7 and MDA-MB-361 human BC xenografts, intracranial U-87 MG glioma xenografts and turpentine-induced inflammation. "
|1.||Amyloid (Amyloid Fibrils)
|3.||Choline (Choline Chloride)
|6.||epigallocatechin gallate (epigallocatechin-3-gallate)
|7.||serum P-component (CIt)
|1.||Heterologous Transplantation (Xenotransplantation)